SG/CALL/FRESENIUS/34/0.1/20.12.24 Share Price

Warrant

DE000SQ6VHB5

Delayed Deutsche Boerse AG 04:47:49 04/07/2024 pm IST
0.052 EUR +1.96% Intraday chart for SG/CALL/FRESENIUS/34/0.1/20.12.24
Current month+8.51%
1 month-37.80%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
04/24/04 0.052 +1.96%
03/24/03 0.051 -1.92%
02/24/02 0.052 -3.70%
01/24/01 0.054 +14.89%
28/24/28 0.047 +9.30%

Delayed Quote Deutsche Boerse AG

Last update July 04, 2024 at 04:47 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying FRESENIUS SE & CO. KGAA
IssuerLogo Issuer Société Générale Société Générale
WKN SQ6VHB
ISINDE000SQ6VHB5
Date issued 29/12/2022
Strike 34
Maturity 20/12/2024 (170 Days)
Parity 10 : 1
Emission price 0.26
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 0.34
Lowest since issue 0.027
Delta0.21x
Omega 10.64
Premium21.3x
Gearing50x
Moneyness 0.8382
Difference Strike 5.415
Difference Strike %+15.93%
Spread 0.01
Spread %16.13%
Intrinsic value 0.000000

Company Profile

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - hospital administration and engineering (64.3%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (35.7%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (72.4%), North America (12.3%), Asia/Pacific (7.3%), Latin America (6.4%) and Africa (1.6%).
Sector
-
More about the company

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius SE & Co. KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
28.46 EUR
Average target price
37.26 EUR
Spread / Average Target
+30.91%
Consensus